Vienna - APHAR

17th Scientific Symposium of the Austrian Pharmacological Society (APHAR)
29–30 September 2011
Location
Departments of Pharmacology
Peter-Mayr-Straße 1 / 1a, A-6020 Innsbruck
Registration Fees and Organisation
Registration Fee:
€ 30.– (Please pay the registration fee at the registration desk)
Reduced registration fee for retired members of APHAR and for students with written
confirmation of student status: € 15.– (The confirmation form can be downloaded from:
http://www.aphar.at/2011/student11.rtf and should be signed by the head of the
institution)
Participation is free of charge for plenary speakers and for APHAR honorary members.
Travel Grants:
Registration Desk:
A limited number of travel grants (€ 250) are available for students of institutions outside
Innsbruck. Please use the application form (http://www.aphar.at/2011/travelGrant2011.rtf) and return it by fax (+43 1 4277-9641).
Grants will be awarded in the order of their arrival.
Institute of Pharmacology, Medical University of Innsbruck
Peter-Mayr-Straße 1a, A-6020 Innsbruck, Tel: +43 (512) 9003-71201, Fax: +43 (512) 9003-73200
e-mail: [email protected]
Opening hours:
Language:
Organisation:
Thu 29 Sep: 08:30 – 16:00
Fri 30 Sep: 08:00 – 12:00
All presentations shall be given in English.
Austrian Pharmacological Society (APHAR)
President: Andrea Laslop, AGES PharmMed,
Tel: + 43 (1) 50555-36800, Fax: +43 (1) 50888-36809, [email protected]
Secretary: Michael Freissmuth, Department of Pharmacology, Medical University of Vienna
Tel: +43 (1) 4277-64171, Fax: +43 (1) 4277-9641,
[email protected]
2
17th Scientific Symposium of the Austrian Pharmacological Society (APHAR)
Thursday, 29 September 2011
Chair: Eva-Maria Zebedin (Vienna)
Short Communications
9:30
A 51
Penetration of polar organic compounds through the blood brain barrier
ª Huba Kalász, Kamil Musílek and Kornélia Tekes (Budapest, Hradec Králové)
9:45
A 37
ª Christian Nanoff, Qiong Yang and Edin Ibrišimović (Vienna)
Autocrine signalling as cause of sensitized cAMP formation
10:00
A 46
[ 11 C]Elacridar as a novel P-glycoprotein PET tracer, assessment of whole-body distribution and
radiation dosimetry in humans
ª Martin Bauer, Markus Zeitlinger, Georg Dobrozemsky, Cécile Philippe, Markus Müller and
Oliver Langer (Vienna, Seibersdorf)
10:15
A 40
Modulation of magnesium deficiency-induced anxiety and HPA axis dysregulation by
therapeutic drug treatment
ª Simone B Sartori, Nigel Whittle, Alfred Hetzenauer and Nicolas Singewald (Innsbruck)
10:30
A 49
ª Asha Leisser, Michael Wolzt and Angela Storka (Vienna)
Salermide down-regulates sirtuin proteins to induce human cancer cell apoptosis
10:45
Posters and Coffee Break
Chair: Bernd Jilma (Vienna)
Plenary Lecture (Clinical Section of APHAR)
11:30
Polymorphic drug metabolizing enzymes in the brain – role in xenobiotic and endogenous
metabolism
ªJulia C. STINGL (Ulm)
12:15
End of session
12:15
Mitgliederversammlung der Sektion Klinische
Pharmakologie
Members of the APHAR Section of Clinical Pharmacology only
Teilnahmeberechtigt sind alle Mitglieder der Sektion Klinische Pharmakologie der APHAR. Gemäß § 12 der Statuten
wird den Sektionsmitgliedern die vorläufige Tagesordnung spätestens vier Wochen vor der Sektionsversammlung
zugeschickt. Gemäß § 3 der Geschäftsordnung der Sektion sind weitere Anträge zur Tagesordnung bis spätestens
sieben Tage vor der Sektionsversammlung bei der Sektionsleitung schriftlich einzureichen.
3
17th Scientific Symposium of the Austrian Pharmacological Society (APHAR)
Thursday, 29 September 2011
Chair: Kornélia Tekes (Budapest)
Short Communications
13:30
A 48
Inhibition of breast cancer resistance protein at the murine blood-brain barrier by Ko143
studied with [ 11 C]tariquidar and PET
ª Thomas Wanek, Claudia Kuntner, Jens P Bankstahl, Marion Bankstahl; Johann Stanek, Michael
Sauberer, Markus Müller, Wolfgang Löscher and Oliver Langer (Vienna, Seibersdorf, Hannover)
13:45
A 60
Properties of the transient outward, ultra-rapid delayed rectifier and acetylcholine-sensitive
potassium currents in isolated atrial myocytes from dogs: sinus rhythm and tachypaced model
of permanent atrial fibrillation
ª Zsófia Kohajda, Attila Kristóf, Péter P Kovács, Claudia Corici, László Virág, Viktor Juhász, Zoltán Husti,
István Baczkó, András Varró and Norbert Jost (Szeged)
14:00
A 29
Characterization of CPCA-induced action on isolated rat femoral artery
ª Miroslav Radenković, R. Stevanović, M. Stojiljković, M. Topalović and Marko Stojanović (Belgrade)
Chair: Jörg Striessnig (Innsbruck)
Plenary Lecture (APHAR lecture)
14:15
Orexin Receptor Pharmacology and Development of Receptor Antagonists
ª Christopher J. WINROW (Dept. Neurosci., Merck Res. Laboratories, West Point, PA, USA)
15:00
Posters and Coffee Break
Chair: Georg Wietzorrek (Innsbruck)
Short Communications
16:00
A 15
Identification of novel ligands interacting with kappa opioid receptors
ª Mariana Spetea, Muhammad F Asim, Ilona P Berzetei-Gurske, Gerhard Wolber and
Helmut Schmidhammer (Innsbruck, Menlo Park, Berlin)
16:15
A 16
Circular plant peptides as templates for GPCR drug discovery?
16:30
A3
Reduced fear conditioning after viral vector mediated neuropeptide Y administration into the
basolateral amygdala
ª Johannes Koehbach, Margaret O’Brien, Marion Miazzo, David J Craik, Michael Freissmuth and
Christian W Gruber (Vienna, Galway, St. Lucia)
ª Dilip Verma, Ramon O Tasan, Mario Mietzsch, Stefan Weger, Regine Heilbronn, Herbert Herzog and
Günther Sperk (Innsbruck, Berlin, Darlinghurst)
Chair: Günther Sperk (Innsbruck)
Plenary Lecture (EPHAR lecture)
16:45
Ghrelin - a novel generation of anti-obesity drug: design, pharmacomodulation and biological
activity of GHS receptor ligands
ª Annette G. BECK-SICKINGER (Inst. of Biochemistry, Leipzig Univ., Germany)
17:30
End of session
17:30
GENERAL ASSEMBLY
Members of the Austrian Pharmacological Society only
Gem. § 9 der Statuten wird den Mitgliedern die vorläufige Tagesordnung spätestens vier Wochen vor der Generalversammlung
zuge-schickt. Weitere Anträge sind mindestens sieben Tage vor dem Termin der Versammlung beim Vorstand schriftlich einzureichen. Teilnahmeberechtigt sind alle ordentlichen Mitglieder, sowie Vertreter der außerordentlichen Mitglieder. Stimmberechtigt
sind nur die ordentlichen Mitglieder.
19:30
APHAR Conference Dinner at Gasthof Planötzenhof
Admittance for registered participants only. For further information see page 10.
4
17th Scientific Symposium of the Austrian Pharmacological Society (APHAR)
Friday, 30 September 2011
Chair: Simone Sartori (Innsbruck)
Short Communications
08:30
A 35
08:45
A8
09:00
A 56
Teaching therapy-oriented pharmacology within a medical curriculum
ª Georg Wietzorrek (Innsbruck)
Pharmacoepidemiological aspects of outpatient pain medication
ª Eva-Maria Zebedin, Barbara Zikulnig, Thomas Burkhart and Anna Bucsics (Vienna)
The double faced role of P2X7 Rreceptors in toxin-induced animal models of Parkinson’s disease
ª Beáta Sperlágh, Zsuzsanna Hracskó, Mária Baranyi, Cecilia Csölle, Flóra Gölöncsér, Ágnes Kittel,
Emilia Madarász (Budapest)
09:15
A 34
Urea induces intercellular adhesion molecule-1 expression
ª Dalia El-Gamal, Michael Holzer, Veronika Binder, Sabine Dirnberger, Ákos Heinemann and
Gunther Marsche (Graz)
09:30
A 54
Can the electrophysiological action of rosiglitazone explain its cardiac side effects?
ª Valéria Kecskeméti, Andrea Szebeni, Norbert Szentandrássy and Péter P Nánási (Budapest,
Debrecen)
09:45
A 59
Effects of diclofenac on ventricular muscle repolarization: proarrhythmic implications
ª Norbert Jost, Attila Kristóf, Zsófia Kohajda, Tamás Szél, Zoltán Husti, István Koncz, Victor Juhász,
István Baczkó, Julius Gy Papp, András Varró and László Virág (Szeged)
10:00
Posters and Coffee Break
Chair: Alexandra Koschak (Vienna)
Plenary Lecture (Hungarian Society of ECP)
11:00
A 55
The rise and fall of CB 1 receptor antagonists: possible future perspectives
11:45
End of session
ª Gyorgy BAGDY (Budapest)
5
17th Scientific Symposium of the Austrian Pharmacological Society (APHAR)
Friday, 30 September 2011
Chair: Harald Sitte (Vienna)
13:00
A 50
Capsaicin-sensitive sensory nerves, TRPV1 Rreceptors and tachykinis play important roles in
mast cell tryptase-induced arthritis and hyperalgesia
ª Zsuzsanna Helyes, Éva Borbély, Katalin Sándor, Adrienn Markovics, Erika Pintér, János Szolcsányi,
John P. Quinn, J.J. McDougall (Pécs, Liverpool, Calgary)
13:15
A 18
Novel pyrazole inhibitors for discrimination between receptor-operated and store-operated
Ca 2+ entry
ª Hannes Schleifer, Regina Oppenrieder, Sonia Stürmer, Bernhard Doleschal, Michael Poteser,
Toma N Glasnov, C Oliver Kappe, Klaus Groschner (Graz)
13:30
A 19
Amphetamine actions rely on the availability of phosphatidylinositol-4,5-bisphosphate
ª Florian Buchmayer, Klaus Schicker, Gerald Stübiger, Peter J Hamilton, Petra Geier, Andreas Jurik,
René Weissensteiner, Thomas Steinkellner, Heinrich J Matthies, Therese Montgomery,
Marie-Therese Winkler, Jae-Won Yang, Marion Holy, Gerhard F Ecker, Aurelio Galli, Valery Bochkov,
Stefan Boehm, Harald H Sitte (Vienna, Nashville)
13:45
A 44
Identification of a new C-terminal splice variant of Ca V 1.3 L-type calcium channels with unique
functional properties
ª Gabriella Juhasz-Vedres, Anja Scharinger, Mathias Gebhart, Perrine Busquet, Chiara Poggiani,
Simone B Sartori, Martina J Sinnegger-Brauns, Alexandra Koschak and Jörg Striessnig (Innsbruck)
14:00
Coffee Break
Chairs: Reiner Fischer-Colbrie (Innsbruck), Peter Holzer (Graz)
HERIBERT KONZETT & HANS HORST MEYER AWARDS
2011
14:30
The Hans Horst Meyer Award of the Austrian Pharmacological Society is awarded
to young investigators in experimental and clinical pharmacology and toxicology.
Donated by Pfizer Corporation Austria.
Award winner: Sonja Sucic (Department of Pharmacology, Medical University of Vienna)
H.H. Meyer
1853 – 1939
The Heribert Konzett Award of the Austrian Pharmacological Society is awarded to
young investigators in experimental and clinical pharmacology in recognition of their
independent research achievements. Donated by AstraZeneca Austria.
Award winner: Christoph Österreicher (Dept. of Pharmacology, Medical University of
Vienna)
Plenary Lecture
15:00
Molecular mechanisms of liver fibrosis
ª Christoph ÖSTERREICHER (Vienna; Heribert Konzett Laureate)
15:30
End of meeting
6
H. Konzett
1912 – 2004
17th Scientific Symposium of the Austrian Pharmacological Society (APHAR)
Thursday & Friday, 29–30 September 2011
Poster Presentations
Posters will be on display for the entire period of the meeting (Thursday and Friday). Presenting
authors are requested to indicate their presence at their poster on the poster board (preferably during
coffee breaks). Dimensions of the poster boards: width 86 cm, height 120 cm.
Austrian Pharmacological Society (APHAR)
A1
The anti-addictive drug ibogaine modulates voltage-gated ion channels and may trigger cardiac
arrhythmias
ª Michael Kovar, Xaver Koenig, Ágnes Mike, René Cervenka, Péter Lukács, Hannes Todt,
A2
Neuropeptide Y Y 2 receptors modulate trace fear conditioning and spatial memory in the dorsal
hippocampus
ª Ramon O Tasan, Dilip Verma, Mario Mietzsch, Stefan Weger, Regine Heilbronn, Herbert Herzog
Walter Sandtner and Karlheinz Hilber (Vienna)
and Günther Sperk (Innsbruck, Berlin, Darlinghurst)
A4
Efficacy of systemic HS-198, an analogue of oxymorphone, on cancer pain-related behaviour in
mice
ª Muhammad F Asim, Catalina R Bohotin, Cristina E Constantin, Helmut Schmidhammer,
A5
Biological, pharmacological and immunological activities of novel 6-amino acid substituted
14-alkoxy- N -methylmorphinans
ª Elena Guerrieri, Valeria Follia, Dorota Garczarczyk, Silvia B Rief, Monika Fink, Muhammad F Asim,
Michaela Kress and Mariana Spetea (Innsbruck)
Mariana Spetea and Helmut Schmidhammer (Innsbruck)
A6
Treprostinil stimulates the engraftment of haematopoetic stem cells
ª Filza Hussain, Christian Bergmayr, Armam Alimohammadi, Michael Freissmuth and
Eva-Maria Zebedin (Vienna)
A7
PI3Kδ is indispensable for CTL-mediated cytotoxicity
ª Eva M Putz, Michaela Prchal, Olivia Simma, Florian Forster, Xaver Koenig, Roland Piekorz,
Michael Freissmuth, Veronika Sexl and Eva-Maria Zebedin (Vienna, Düsseldorf)
A9
Morphological characterization of large intercalated neurons provides novel insight on intrinsic
networks of the amygdala
ª Daniela Busti, Thomas Bienvenu, Ben Micklem, Peter J Magill, Ryuichi Shigemoto, Marco Capogna
and Francesco Ferraguti (Innsbruck, Oxford, Okazaki)
A 10
Activation of kappa opioid receptors reduces EEG seizure activity in a mouse model of temporal
lobe epilepsy
ª Luca Zangrandi and Christoph Schwarzer (Innsbruck)
A 11
Structural determinants of Ca V 1.3 L-type calcium channel gating
ª Andreas Lieb, Anja Scharinger, Florian Hechenblaickner, Mathias Gebhart, Alexandra Koschak,
Martina J Sinnegger-Brauns and Jörg Striessnig (Innsbruck)
A 12
Timothy mutation affects tightly sealing point of Ca V 1.2 activation gate
ª Katrin Depil, Stanislav Beyl, Anna Stary-Weinzinger, Annette Hohaus, Eugen Timin and
Steffen Hering (Vienna)
A 13
Development of novel N -methyl and N -allyl-substituted oxazolomorphinans and their interaction
with opioid receptors
ª Attila Sipos, Levente Girán, Sándor Berényi, Sándor Antus, Helmut Schmidhammer and
Mariana Spetea (Debrecen, Innsbruck)
A 14
Bacterial peptidoglycan enhances sickness behaviour induced by bacterial lipopolysaccharide
ª Aitak Farzi, Evelin Painsipp and Peter Holzer (Graz)
A 17
Neurodegeneration and histochemical plasticity in the rat subiculum after kainic acid-induced
epilepsy
ª Meinrad Drexel, Adrian P Preidt, Elke Kirchmair and Günther Sperk (Innsbruck)
7
17th Scientific Symposium of the Austrian Pharmacological Society (APHAR)
Thursday & Friday, 29–30 September 2011
Poster Presentations
Posters will be on display for the entire period of the meeting (Thursday and Friday). Presenting
authors are requested to indicate their presence at their poster on the poster board (preferably during
coffee breaks). Dimensions of the poster boards: width 86 cm, height 120 cm.
Austrian Pharmacological Society (APHAR)
A 20
Truncations in the amino terminus reveal a region key to supporting amphetamine-induced efflux
by the human serotonin transporter
ª Sonja Sucic, Carina Kern, Dragana Vidovic, Subhodeep Sarker, Oliver Kudlacek, Harald H Sitte and
Michael Freissmuth (Vienna)
A 21
LRET-based intramolecular distance measurements in LeuT Aa
ª Azmat Sohail, Peggy Stolt-Bergner, Gerhard F Ecker, Michael Freissmuth, Thomas Stockner,
A 22
The transcription factor STAT5 drives mutation and imatinib resistance in chronic myeloid leukemia
via ROS production
ª Eva Grundschober, Wolfgang Warsch and Veronika Sexl
A 23
Statins modulate the expression profile of ATP-binding cassette transporters in human
neuroblastoma cells
ª Bihter Atil, Evelyn Sieczkowski and Martin Hohenegger (Vienna)
A 24
Interaction of V-type ATPase inhibitors and extracellular NAADP-triggered calcium release in
skeletal muscle cells
ª Florian Hiess and Martin Hohenegger (Vienna)
A 25
Simvastatin targets the IL-6 signalling cascade in human melanoma cells
ª Christine Wasinger, Christoph Minichsdorfer, and Martin Hohenegger (Vienna)
A 26
Introduction of a 6-cyano group in 14-oxygenated N-methylmorphinans influences in vitro and in
vivo pharmacological activities
ª Valeria Follia, Mario D Aceto, Louis S Harris, Andrew Coop, Helmut Schmidhammer and
Mariana Spetea (Innsbruck, Richmond, Baltimore)
A 27
Expression and differential distribution of the shaker-related voltage-gated potassium channel
family (K V 1.x) in human hippocampus and neocortex
ª Irmgard Leitner, Georg Wietzorrek, Maria Trieb, Josef Marksteiner and Hans-Günther Knaus
Harald H Sitte and Walter Sandtner (Vienna)
(Innsbruck, Hall)
A 28
Current-clamp experiments on primary hippocampal neurons shed light on the role of L-type
voltage-gated calcium channels in depolarization shifts
ª Helmut Kubista, Lena Rubi, Petra Geier, Michael Lagler and Stefan Boehm (Vienna)
A 30
Differential modulation of rNa V 1.4 channel inactivated states by lidocaine and its charged analogue
QX222
ª Péter Lukács, René Cervenka, Xaver Koenig, Ágnes Mike, Michael Kovar, Karlheinz Hilber and
Hannes Todt (Vienna)
A 31
Characterising the interaction between the COPII component SEC24C and the human serotonin
transporter
ª Florian Koban and Sonja Sucic (Vienna)
A 32
Uremic albumin blocks reverse cholesterol transfer: role of lysine modifications
ª Veronika Binder, Michael Holzer, Dalia El-Gamal, Sabine Dirnberger and Gunther Marsche (Graz)
A 33
Screening for serine/threonine kinases phosphorylating Stat5
ª Angelika Berger, Andrea Hölbl, Wolfgang Warsch and Veronika Sexl (Vienna)
A 36
ABC transporters of Fasciola hepatica as putative drug targets
ª Ali El-Kasaby, Thomas Stockner and Oliver Kudlacek (Vienna)
8
17th Scientific Symposium of the Austrian Pharmacological Society (APHAR)
Thursday & Friday, 29–30 September 2011
Poster Presentations
Posters will be on display for the entire period of the meeting (Thursday and Friday). Presenting
authors are requested to indicate their presence at their poster on the poster board (preferably during
coffee breaks). Dimensions of the poster boards: width 86 cm, height 120 cm.
Austrian Pharmacological Society (APHAR)
A 38
Differential regulation of amphetamine-induced serotonergic and dopaminergic efflux by
syntaxin 1A
ª Therese Montgomery, Sonja Sucic, Thomas Steinkellner, Michael Freissmuth and Harald Sitte (Vienna)
A 39
129S1/SvImJ mice display impaired contextual fear extinction, enhanced fear incubation and deficit
extinction consolidation phenotypes: rescue via pharmacological and non-pharmacological
treatments
ª Nigel Whittle, Markus Hauschild, Marguerite Camp, Andrew Holmes and Nicolas Singewald
A 41
The folding interactome of GPCRs
ª Christian Bergmayr, Christian Nanoff, Oliver Kudlacek, Michael Freissmuth and Christian W Gruber
(Innsbruck, Bethesda)
(Vienna)
A 42
Fear learning induces structural and functional plasticity at GABAergic synapses in the basolateral
amygdala
ª Yu Kasugai, Elisabeth Vogel, Markus Hauschild, Ramon O Tasan, Yvan Peterschmitt,
Andreas Lüthi, Ryuichi Shigemoto, Werner Sieghart, Nicolas Singewald, Günther Sperk and
Francesco Ferraguti (Innsbruck, Basel, Okazaki, Vienna)
A 43
Septal urocortin 3 modulates stress-coping behaviour but not hypothalamic-pituitary-adrenal axis
activity during forced swimming
ª Karl Ebner, Alesja Rjabokon and Nicolas Singewald (Innsbruck)
A 57
The G protein-coupled receptor-associated protein 1 (GASP-1) regulates rimonabant-induced
downregulation of GPR55
ª Julia Kargl, Nariman A Balenga, Jennifer L Whistler and Maria Waldhoer (Graz, Bethesda, San Francisco)
A 58
The D-type prostanoid (DP) receptor enhances the signaling of chemoattractant receptorhomologous molecule expressed on Th2 cells (CRTH2)
ª Ram Miriam Sedej, Ralf Schröder, Kathrin Bell, Wolfgang Platzer, Evi Kostenis, Ákos Heinemann
and Maria Waldhoer (Graz, Bonn)
APHAR Section of Clinical Pharmacology
A 45
Effect of orally administered moxaverine on ocular haemodynamics
ª Stefan Palkovits, Michael Lasta, Doreen Schmidl, Agnes Boltz, Reinhard Told, Semira Kaya,
Gerhard Garhöfer and Leopold Schmetterer (Vienna)
A 47
Role of nitric oxide in optic nerve head blood flow regulation while experimental increase of ocular
perfusion pressure
ª Reinhard Told, Doreen Schmidl, Michael Lasta, Agnes Boltz, Berthold Pemp, Semira Kaya,
Gerhard Garhöfer, Gabriele Fuchsjäger-Mayrl and Leopold Schmetterer (Vienna)
Hungarian Society for Exp. & Clin. Pharmacology (MFT)
A 52
Stability monitoring of some acetylcholinesterase reactivating drugs
ª Nazila Ram, Péter Szegi, Kamil Kuča, Farzad Hashemi & Kornélia Tekes (Budapest, Hradec Králové)
A 53
Electrophysiological effects of rosiglitazone on heart ventricular papillary muscles of control and
diabetic histidine decarboxylase knock-out and wild-type mice
ª Andrea Szebeni, Ágnes Kovács and Valéria Kecskeméti (Budapest)
9
17th Scientific Symposium of the Austrian Pharmacological Society (APHAR)
Thursday, 29 September 2011
APHAR Conference Dinner (Gasthof Planötzenhof)
Admittance for registered
participants only.
Menu:
Kürbiscreme Suppe
Kalbsbraten vom hofeigenen Milchkalb
mit Reis, Kroketten und Gemüse
Kuchenduo
A vegetarian menu can be requested
until September 26 by email
([email protected])
Date:
Thursday
29. September 2011
Time:
19:30
Location: Gasthof Planötzenhof (A)
Planötzenhofstr. 30
6020 Innsbruck
Tel: 0512-27401
can be reached by a 15 min uphill
walk from final station Sadrach of
Bus A or by taxi
Austrian Pharmacological Society (APHAR):
Executive Committee:
President: Andrea Laslop (Vienna), Vice-President: Peter Holzer (Graz), Secretary Gen.: Michael Freissmuth (Vienna),
Treasurer: Barbara Valenta (Vienna), President of the Section of Clinical Pharmacology: Brigitte Blöchl-Daum (Vienna),
Further Member: Reiner Fischer-Colbrie (Innsbruck).
Clinical Pharmacology Section Committee:
President: Brigitte Blöchl-Daum (Vienna), Vice-President: Bernd Jilma (Vienna),
Further Member of the Council of the Section: Markus Zeitlinger (Vienna).
ZVR-Zahl: 202359700 Website:
http://www.aphar.at/
Supporting Members of APHAR:
The EPHAR Lecture is sponsored by EPHAR, the Federation of European Pharmacological
Societies, with support from the British Pharmacological Society
10
Österreichische Pharmakologische Gesellschaft
Austrian Pharmacological Society
y APHAR y
Vorsitzende:
Univ.-Prof. Dr. Andrea Laslop
AGES Österreichische Agentur für
Gesundheit und Ernährungssicherheit
Schnirchgasse 9
A-1030 Wien
Tel. +43 (50555) 36800
Fax +43 (50555) 36809
[email protected]
Geschäftsführer:
Univ.-Prof. Dr. Michael Freissmuth
Institut für Pharmakologie, Zentrum für
Biomolekulare Medizin und Pharmakologie
Währinger Straße 13a
A-1090 Wien
Tel. +43 (1) 4277-64171
Fax +43 (1) 4277-9641
[email protected]
ZVR-Zahl: 202359700
Kassier:
Dr. Barbara Valenta
Baxter BioScience
Wagramer Straße 17-19, IZD
A-1220 Wien
Tel. +43 (1) 20100-2930
Fax +43 (1) 20100-534
[email protected]
www.aphar.at
ANSUCHEN UM AUFNAHME
†
als
(†
ordentliches Mitglied
Dissertant)
(gem. § 5 der Statuten können alle Personen, die aktiv auf dem Gebiet der Pharmakologie in Forschung, Lehre oder
Administration tätig sind und entweder ein abgeschlossenes Universitätsstudium besitzen oder sich im Dissertationsstadium befinden, Mitglieder der APHAR werden. Bei Dissertanten wird um Bestätigung des Institutsvorstandes gebeten.)
Mitgliedschaft in der Sektion Klinische Pharmakologie gewünscht: † Ja
(gem. § 12 der Statuten können ordentliche Mitglieder der APHAR, die aktiv auf dem Gebiet
der Klinischen Pharmakologie in Forschung, Lehre oder Administration tätig sind, Mitglieder
der Sektion Klinische Pharmakologie werden.)
†
† Nein
förderndes Mitglied
)
(mit * gekennzeichnete Felder nicht auszufüllen bei Antrag um Aufnahme als förderndes Mitglied.)
* ) Name:
Zuname
Vorname
* ) Akad. Grad:
* ) Berufstitel:
* ) Ausbildung:
Derzeitiges Arbeitsgebiet:
Institut/Firma:
Anschrift:
Tel:
Fax:
!! e-mail:
Datum:
Unterschrift:
Befürwortendes Mitglied der Gesellschaft:
* ) Name:
Unterschrift:
Î Das ausgefüllte Formular bitte an den Geschäftsführer der APHAR schicken
(M. Freissmuth, Institut für Pharmakologie, Währinger Straße 13a, 1090 Wien, Fax: 01 / 4277-9641).
Stellvertretender Vorsitzender: Univ.-Prof. Dr. Peter Holzer (Graz); Vorsitzende der Sektion Klinische Pharmakologie: Univ.-Prof. Dr. Brigitte Blöchl-Daum (Wien); weiteres
Vorstandsmitglied: Univ.-Prof. Dr. Reiner Fischer-Colbrie (Innsbruck); Bankverbindung: Österreichische Postsparkasse, BLZ (Swift Code OPSKATWW), Kto.Nr. 920 551 59